- Poster presentation
- Open Access
Sphingosine-1 phosphate promotes thymic atrophy during sepsis progression
© Kuchler et al.; licensee BioMed Central Ltd. 2014
Published: 3 December 2014
T-cell depletion is a marker of the hypo-inflammatory phase of sepsis [1, 2]. Systemic T-cell loss could be caused i.a. by thymus involution during sepsis, thus contributing to immune paralysis . Usually, thymic T-cell egress is mediated by a sphingosine-1-phosphate (S1P) gradient. That is, T cells leave the thymus towards an increased S1P-level in the periphery (blood/lymph) . A disruption of this S1P gradient blocks T-cell emigration. S1P is produced by sphingosine kinases 1 and 2 (SPHK1 and SPHK2), which are ubiquitously expressed . Apoptotic cells are known to release S1P . We suggest that apoptotic events in the thymus during sepsis increase S1P levels, thereby disrupting the gradient and preventing egress of T cells from the thymus.
We used a murine polymicrobial sepsis model to analyze thymus involution. Sepsis is induced in wildtype mice, SPHK1-/-, or SPHK2-/- mice by cecal ligation and puncture (CLP). Thymus involution was determined by analyzing the T-cell amount of single-positive mature (CD4+CD8- vs. CD4-CD8+), double-positive late immature (CD4+/CD8+), and double-negative early immature cells by FACS analysis. T cells from SPHK1-/- or SPHK2-/- mice, which produce less S1P, and wildtype mice treated with a SPHK1 inhibitor were used to characterize whether T cells in these mice have a higher rate of emigration compared to control mice. Thymic and serum S1P levels were quantified by LC-MS/MS. Apoptosis was determined by annexin V FACS staining. SPHK mRNA levels were determined by qPCR.
The thymus of septic mice showed more CD3-positive cells but a decreased number of CD4/CD8 double-positive T cells, pointing to a thymic retention of single-positive mature T cells. In line with our assumption, CLP causes apoptosis of thymocytes and increases SPHK1 mRNA expression. Concomitantly S1P levels are increased in the thymus and consequently decreased in serum following CLP. The knockout of the S1P producing sphingosine-kinases SPHK1 or SPHK2 and the pharmacological inhibition of SPHK1 restores T-cell egress as indicated by an increase of double-positive immature T cells compared to wildtype mice.
Our data suggest that inhibition of SPHK1-mediated S1P generation during sepsis restores thymic T-cell egress, which might improve septic outcome. Therefore, understanding mechanisms of thymus involution during sepsis may help to reconstitute thymic function, finally improving immune reactions in the hypoinflammatory phase of sepsis.
- Soller M, Tautenhahn A, Brüne B, Zacharowski K, John S, Link H, von Knethen A: Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J Leuk Biol 2006, 79: 235-243.View ArticleGoogle Scholar
- Schmidt MV, Paulus P, Kuhn A-M, Weigert A, Morbitzer V, Zacharowski K, Kempf VAJ, Brüne B, von Knethen A: Peroxisome proliferator-activated receptor gamma-induced T cell apoptosis reduces survival during polymicrobial sepsis. Am J Respir Crit Care Med 2011, 184: 64-74. 10.1164/rccm.201010-1585OCView ArticlePubMedGoogle Scholar
- Verinaud V, de Souza Souto P, Niéto Brito V: Thymic atrophy in infectious diseases. Braz J Morphol Sci 2004, 21: 111-116.Google Scholar
- Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG: Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427: 355-360. 10.1038/nature02284View ArticlePubMedGoogle Scholar
- Spiegel S, Milstien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003, 4: 397-407. 10.1038/nrm1103View ArticlePubMedGoogle Scholar
- Weigert A, Johann AM, von Knethen A, Schmidt H, Geisslinger G, Brüne B: Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 2006, 108: 1635-1642. 10.1182/blood-2006-04-014852View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.